| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |